Major U.S. employers are expressing profound frustration over persistently rising healthcare costs, which they perceive as lacking logical justification. This discontent is fueling a significant surge in the consideration of switching health insurance and pharmacy benefits providers, according to a comprehensive new survey of prominent U.S. purchasers. The findings, released by the Purchaser Business Group on Health (PBGH), a nonprofit coalition representing 40 of the nation’s largest healthcare purchasers, reveal a palpable shift in employer strategy. Collectively, these organizations spend over $350 billion annually to cover 21 million workers and their dependents, underscoring the substantial economic impact of their decisions.
The survey indicates that a considerable 37% of PBGH members have initiated a "request for proposals" (RFP) process for their medical benefits. This signifies a proactive effort to shop for new insurance providers, a marked increase from just 12% in 2024, the last time PBGH conducted a similar survey on this specific issue. The undertaking of switching vendors is inherently complex and costly for employers, often involving extensive due diligence, contract negotiations, and implementation challenges. However, the escalating financial burden of healthcare spending is compelling these organizations to explore more aggressive measures to regain control of their benefit expenditures.
The surge in RFPs for medical benefits is mirrored in the pharmacy benefits sector. Currently, 23% of PBGH members are actively seeking new pharmacy benefits managers (PBMs), a slight uptick from 20% in 2024. This sustained interest in reassessing PBM relationships highlights a growing dissatisfaction with the current system, particularly concerning the rising cost of prescription drugs.
The Unrelenting Rise of Healthcare Expenses
The PBGH’s findings align with a broader landscape of escalating healthcare costs that are placing immense pressure on employers. These rising expenses are attributed to a confluence of factors, including the escalating price of pharmaceuticals, the increasing prevalence of chronic health conditions among the workforce, and the ongoing consolidation of healthcare providers, which can reduce competition and drive up prices. Various industry estimates project that the cost of employer-sponsored health benefits will increase by approximately 6% to 8% this year alone.
This relentless cost inflation is forcing employers into difficult decisions. Many are compelled to pass a greater portion of these expenses onto their employees through higher premiums, deductibles, and copayments. This strategy, while intended to alleviate the employer’s financial strain, comes at a significant cost to workers, who are already grappling with steep premiums and the increasing likelihood of foregoing necessary medical care due to affordability concerns. Recent reports indicate that a growing number of Americans are making difficult choices about their healthcare needs, opting to delay or skip treatments and prescriptions due to prohibitive costs.
Employers Target Vendor Relationships for Cost Control
In response to these pressures, employers are intensifying their scrutiny of vendor relationships across the entire healthcare ecosystem. This includes not only seeking out new providers but also renegotiating existing contracts with current partners and discontinuing programs that demonstrate low utilization or poor value for their members. The focus is on identifying inefficiencies and exploring avenues for more cost-effective solutions.
A particularly acute area of frustration for employers lies with their pharmacy benefits vendors. The escalating cost of prescription drugs has become a significant budgetary stressor, leading many businesses to question the value and transparency of their current PBM arrangements. A growing number of companies are moving away from traditional, large-scale PBMs, such as CVS Caremark, Express Scripts (a Cigna company), and Optum Rx (part of UnitedHealth Group). These employers cite concerns over hidden fees, potential conflicts of interest (self-dealing), and the opaque nature of PBM contracts. The "black box" nature of these agreements, as described by critics, often leaves health insurers and employers with limited visibility into how their money is being spent and whether they are receiving the best possible pricing.
The Rise of Alternative Pharmacy Benefit Models
This dissatisfaction is directly fueling a migration toward alternative pharmacy benefit models. Employers are increasingly exploring options such as contracting with "transparent" PBMs, which operate on a flat administrative fee model, or outsourcing specific pharmacy benefit functions to a variety of specialized vendors. This approach aims to bring greater clarity and control to prescription drug spending.
The PBGH survey highlights the growing adoption of these non-traditional PBM arrangements. Currently, 27% of PBGH members are utilizing such models, a substantial increase from just 16% in 2024. This trend suggests a fundamental shift in how employers are approaching PBM management, moving away from a one-size-fits-all model toward more tailored and cost-conscious solutions.
Michael Costello, a PBGH board member and strategy director at NextEra Energy, articulated this sentiment in a statement, emphasizing employers’ commitment to their fiduciary responsibilities. "Employers are taking their fiduciary obligations seriously, innovating their procurement strategies and seeking aligned partners that are truly interested in working to address employer needs, not just to maximize their own profits," Costello stated. This highlights a desire for partnerships built on mutual benefit and a shared commitment to cost containment and improved member outcomes.
Transparency Emerges as a Key Demand
Beyond affordability, the PBGH survey identified data and transparency as the next most pressing concerns for its members. Employers are actively seeking clearer, more accessible information regarding the pricing of healthcare procedures and other critical data points that can help them identify opportunities for cost savings and optimize their benefit plans.
This emphasis on transparency is not confined to employer-led initiatives. Policymakers at both the federal and state levels have also recognized transparency as a crucial lever for controlling healthcare costs. In recent years, legislative efforts have been made to enhance transparency requirements within the healthcare industry. For instance, new PBM disclosure requirements were incorporated into government funding legislation earlier this year. Furthermore, the Trump administration had previously made strengthening price transparency for insurers a central tenet of its health affordability agenda. These governmental actions, alongside employer demands, are creating a more transparent and accountable healthcare market.
Implications for the Healthcare Landscape
The intensified scrutiny of healthcare vendors by large employers has significant implications for the broader healthcare market. The increased use of RFPs and the growing adoption of alternative PBM models suggest a potential disruption to the established order, particularly for large, incumbent PBMs. These organizations may face increased pressure to adapt their business models, enhance transparency, and demonstrate greater value to maintain their market share.
For employers, this evolving landscape offers the potential for greater cost control and more tailored benefit solutions. However, the transition to new vendors and models requires careful planning and execution. The success of these strategies will depend on the ability of employers to effectively assess their needs, conduct thorough due diligence, and forge partnerships with providers who are genuinely committed to shared goals of affordability and quality.
The ongoing pursuit of transparency also holds the promise of empowering consumers and purchasers with better information, enabling more informed decision-making. As more data becomes available regarding the cost and quality of healthcare services, the dynamics of the market are likely to shift, potentially leading to greater competition and innovation.
The PBGH survey’s findings represent a clear signal that employers are no longer content to passively absorb escalating healthcare costs. Their willingness to engage in more aggressive procurement strategies and to explore new vendor relationships underscores a growing demand for accountability, transparency, and demonstrable value within the U.S. healthcare system. This proactive stance by major purchasers could be a catalyst for meaningful change, driving greater efficiency and affordability for millions of American workers and their families.
About the Author
